PA-24-247 - PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 49
Active NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|
Expired NOSIs
| Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STTR) | NOT-EY-24-014 | NEI NCATS NCI NHLBI NIBIB | Sep 20, 2024 | Sep 9, 2025 | R43/R44, R41/R42 |
| Notice of Special Interest: Small Business Solutions to Enable Regional Genomic Medicine eConsult Services | NOT-HG-24-041 | NHGRI | Sep 4, 2024 | Sep 9, 2025 | R41/R42, R43/R44 |
| Notice of Special Interest: Small Business Solutions to Assist Genomics-Enabled Learning Health Systems (gLHS) | NOT-HG-24-040 | NHGRI | Sep 4, 2024 | Sep 9, 2025 | R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): Advancing Precision Imaging for Enhanced Diagnosis and Treatment of Oral Lesions | NOT-DE-25-034 | NIDCR | Aug 30, 2024 | Sep 9, 2025 | UG3/UH3, R43/R44, R01, R41/R42, R21 |
| Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application | NOT-HG-24-036 | NHGRI | Jul 25, 2024 | Sep 9, 2025 | R01, R41/R42, R21, R43/R44 |
| Notice of Special Interest (NOSI): Epigenetic Modulation of HBV cccDNA and integrated HBV DNA (iDNA): Implications for Epigenetic Treatment Strategies Against HBV in HIV/HBV Co-Infection | NOT-AI-24-050 | NIAID | Jun 28, 2024 | Sep 9, 2025 | R41/R42, R43/R44, R01, R21 |
| Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health | NOT-OD-24-146 | OBSSR NCCIH NCI NEI NHLBI NIA NIDA NIMH NIMHD NINR OAR ODP ORWH | Jun 24, 2024 | Sep 9, 2025 | P01, P30, R01, R03, UG3/UH3, R34, U24, R41/R42, R21, R43/R44, R21/R33, R61 |
| Notice of Special Interest (NOSI): Translating Biomaterials-Based Technologies to Commercially Viable Products | NOT-EB-24-001 | NIBIB NCATS NCCIH NHLBI NIDCR | Mar 29, 2024 | Sep 9, 2025 | R41/R42, R43/R44 |
| Notice of Special Interest (NOSI): Research to Stimulate Development of Diagnostics, Therapeutics, and Vaccines for Herpes Simplex Virus (HSV) | NOT-AI-24-028 | NIAID | Mar 27, 2024 | Sep 9, 2025 | R21, R41/R42, R43/R44, R03, R01 |
| Notice of Special Interest: Womens Health Research | NOT-OD-24-079 | ORWH FIC NCATS NCCIH NCI NEI NHGRI NHLBI NIA NIAAA NIAID NIAMS NIBIB NICHD NIDA NIDCD NIDCR NIDDK NIEHS NIGMS NIMH NIMHD NINDS NINR NLM OAR OBSSR ODP ODS ODSS | Mar 26, 2024 | Sep 9, 2025 | R15, R01, K01, R16, K08, R21, K43, F31, R43/R44, R41/R42, F30, R03, K23, F32, R34 |
| Notice of Special Interest (NOSI): Development of Imaging Techniques for High Resolution and Functional Scanning of In Vivo Human Sensory and Communication Systems | NOT-DC-24-025 | NIDCD | Mar 22, 2024 | Sep 9, 2025 | R01, U01, R43/R44, R41/R42, R21 |
| Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research | NOT-CA-24-031 | NCI NHLBI NIA NIDA NIMH NINR OBSSR ODSS | Feb 15, 2024 | Jul 6, 2025 | R61/R33, R01, R21, R43/R44, R34, R41/R42 |
| Notice of Special Interest (NOSI): Innovative Technologies for Research on Climate Change and Human Health | NOT-ES-24-002 | NIEHS NCATS NCCIH NEI NHLBI NIA NIAID NIAMS NLM | Feb 15, 2024 | Apr 6, 2025 | R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): Advancing Genomic Medicine Research through Small Businesses | NOT-HG-24-016 | NHGRI | Feb 14, 2024 | Sep 9, 2025 | R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): RNA Delivery Technologies to Allow Specific Tissue Target Homing (RNA-DASH) | NOT-AI-24-007 | NIAID NCATS NCI | Feb 2, 2024 | Sep 9, 2025 | R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace | NOT-MH-24-115 | NIMH NCCIH NEI NIA NIAAA NIBIB NICHD NIDA NIDCD NINDS | Jan 8, 2024 | Sep 9, 2025 | R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application | NOT-HG-24-012 | NHGRI | Dec 20, 2023 | Sep 30, 2024 | R01, R21, R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): SBIR/STTR High-Priority Areas for Digital Mental Health Innovations | NOT-MH-24-120 | NIMH | Nov 29, 2023 | Sep 9, 2025 | R41/R42, R43/R44 |
| Notice of Special Interest (NOSI): SBIR/STTR Program Priorities to Bridge Gaps in Advancing the NIMH Mission | NOT-MH-24-110 | NIMH | Nov 29, 2023 | Sep 9, 2025 | R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives | NOT-AI-23-076 | NIAID | Oct 31, 2023 | Sep 9, 2025 | R03, R01, R21, R41/R42, R43/R44 |
| Notice of Special Interest (NOSI): Advancing Genomic Medicine Research through Small Businesses | NOT-HG-24-002 | NHGRI | Oct 11, 2023 | Sep 9, 2025 | R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): The Road to Prevention of Stillbirth | NOT-HD-23-021 | NICHD | Oct 3, 2023 | Sep 9, 2025 | F31, R03, R15, K08, R01, R21, F30, U24, R43/R44, K23, R41/R42, R25, S06, F32, U01 |
| Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STRR) | NOT-EY-23-009 | NEI NCATS NCI | Sep 6, 2023 | Sep 6, 2024 | R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal Health | NOT-EB-23-005 | NIBIB NCATS NHLBI NIAMS NIMH NIMHD NINDS ORWH | Jul 26, 2023 | Sep 9, 2025 | U44, R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): Innovative Technologies to develop novel tools to prevent and treat HIV in underserved populations | NOT-MH-23-200 | NIMH | Jul 18, 2023 | Sep 9, 2025 | R41/R42, R43/R44 |
| Notice of Special Interest (NOSI): Advancing Biomedical Research in Pulmonary Non-Tuberculous Mycobacterial (NTM) Infections | NOT-AI-23-050 | NIAID | Jun 27, 2023 | Sep 9, 2025 | R21, R41/R42, R43/R44, R01, U44 |
| Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives | NOT-AI-23-049 | NIAID | Jun 23, 2023 | Sep 9, 2025 | R03, R01, R41/R42, R43/R44, R21 |
| Notice of Special Interest (NOSI): Promoting Research and Development of Vaccines Against Enteric Viruses | NOT-AI-23-048 | NIAID | Jun 15, 2023 | Sep 9, 2025 | R01, R43/R44, U44, R41/R42, R21 |
| Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults | NOT-MH-23-250 | NIMH | May 19, 2023 | Sep 9, 2025 | K43, R41/R42, R21, K08, R25, K99/R00, T32, K01, F30, R34, R03, F31, R15, R43/R44, K24, K23, F32, R01 |
| Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications. | NOT-EB-23-002 | NIBIB NCCIH NCI NHLBI NIA NIAID NICHD NIGMS | Apr 14, 2023 | Sep 9, 2025 | R01, R21, R35, R41/R42, R43/R44 |
| Notice of Special Interest (NOSI): Development of Innovative Informatics and Data Science Technologies, Tools, and Methods for Vision Research | NOT-EY-23-005 | NEI | Apr 3, 2023 | Sep 9, 2025 | R41/R42, R43/R44, R21 |
| Notice of Special Interest (NOSI): Promoting Language and Communication in Minimally Verbal/Non-Speaking Individuals with Autism | NOT-DC-23-009 | NIDCD | Apr 3, 2023 | Sep 9, 2025 | R13, R15, R01, U01, R21, R43/R44, R41/R42, R03 |
| Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine | NOT-AI-23-031 | NIAID | Feb 23, 2023 | Sep 9, 2025 | R01, R41/R42, R43/R44, R21, U44 |
| Notice of Special Interest (NOSI): Small Business Digital Technologies for Early Detection, Characterization and Monitoring of Senescence-Related Changes | NOT-AG-23-004 | NIA | Feb 7, 2023 | Sep 9, 2025 | R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): Development of Functional Assay Sites to Evaluate Candidate -Omics Variants Associated with Heart, Lung, Blood, or Sleep Disease (R01, R41, R42, R43, R44) | NOT-HL-23-066 | NHLBI | Jan 31, 2023 | Sep 9, 2025 | R41/R42, R43/R44, R01 |
| Notice of Special Interest (NOSI): Optimization of Data Storage and Utilization for the Sequence Read Archive (SRA) | NOT-GM-23-015 | NIGMS NLM ODSS | Dec 14, 2022 | Sep 9, 2025 | R41/R42, R43/R44, R01, K08, RM1, R21, K25, K99/R00, K23, F30, F32, F33, F31, R16, R35, R15 |
| Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine | NOT-AI-23-007 | NIAID | Nov 25, 2022 | Sep 9, 2025 | R21, R41/R42, R43/R44, R01 |
| Notice of Special Interest (NOSI): Advancing Research for Tickborne Diseases (TBDs) | NOT-AI-23-013 | NIAID NIAMS NIMH NINDS | Nov 25, 2022 | Sep 9, 2025 | R43/R44, R15, R01, R21, R03, R41/R42 |
| Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics | NOT-AI-23-001 | NIAID NCI NIBIB | Nov 23, 2022 | Sep 9, 2025 | R01, R41/R42, R43/R44, R21 |
| Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers | NOT-CA-23-004 | NCI | Oct 17, 2022 | Jul 2, 2025 | R43/R44, R21, R01, UH2/UH3, R41/R42, U01 |
| Notice of Special Interest (NOSI): Towards Developing a Cure for HBV in HIV/HBV Co-Infection | NOT-AI-22-043 | NIAID | Apr 29, 2022 | May 8, 2025 | R01, R41/R42, R21, R43/R44 |
| Notice of Special Interest (NOSI): Research Addressing Eye and Vision Health Equity/Health Disparities | NOT-EY-22-004 | NEI NIMHD | Feb 14, 2022 | Jan 25, 2025 | R01, UG1, F31, R21, 333, K99/R00, K08, F30, K23, R43/R44, R34, R41/R42, F32 |
| Notice of Special Interest (NOSI): Advancing NEI AGI Research on newly Identified Factors Into Models of Visual System Regeneration | NOT-EY-22-002 | NEI | Jan 10, 2022 | Feb 10, 2025 | R43/R44, R21, R15, R41/R42, R01, R24 |
| Notice of Special Interest: Research on Pain, Pain Management, and Opioids in Aging | NOT-AG-22-004 | NIA | Dec 22, 2021 | Jan 8, 2025 | F31, P01, K99/R00, K08, R01, K01, R43/R44, F32, 332, F33, F99/K00, R15, K24, R21, K02, K25, R25, F30, K23, R36, R41/R42, SB1, K76, K22, K07, R13, R21/R33, U19 |
| Notice of Special Interest (NOSI): Methods Development for Genomic Studies of Genetic Variation, Function, and Disease | NOT-HG-22-007 | NHGRI | Dec 9, 2021 | Nov 5, 2024 | R41/R42, R01, R43/R44, R21 |
| Notice of Special Interest (NOSI): Epidemiology and Prevention of Alcohol Misuse in Understudied Young Adult Populations; Military, Workforce, and Community College | NOT-AA-22-001 | NIAAA | Dec 9, 2021 | Sep 9, 2025 | R21, R03, R01, R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R41/R42, R43/R44 Clinical Trial Not Allowed) | NOT-DE-21-012 | NIDCR | Sep 1, 2021 | Sep 5, 2025 | R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): Genomics Education Interactive Digital Media Resources (SBIR/STTR) | NOT-HG-21-038 | NHGRI | Aug 26, 2021 | Dec 31, 2024 | R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): National Cancer Institute SBIR/STTR Program Announcement Regarding Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings | NOT-CA-21-062 | NCI | Jul 23, 2021 | Sep 7, 2024 | R43/R44, R41/R42 |

